Introduction of MP-AzeFlu nasal spray for individuals with allergic rhinitis in Saudi Arabia and the United Arab Emirates: a budget impact analysis
The introduction of MP-AzeFlu in Saudi Arabia and the United Arab Emirates showed cost-neutral to cost-saving impacts, depending on whether it replaces dual or triple therapy regimens.
Authors
- Rajesh Kumar Ramalingam (ORCID: https://orcid.org/0000-0003-0690-1283)
- Richard A. Thompson (ORCID: https://orcid.org/0000-0002-2679-9418)
- Ferdinand Kopietz (ORCID: https://orcid.org/0000-0002-5398-0626)
- Jatin Agarwal
- Yazed AlRuthia (ORCID: https://orcid.org/0000-0002-0029-5924)
Institutions
- King Saud University (SA)
- Health Outcomes Solutions (United States) (US)
- ENT and Allergy (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1080/03007995.2025.2583563
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00